Welcome to our dedicated page for Zepp Health Corporation news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health Corporation stock.
Zepp Health Corporation (NYSE: ZEPP) drives innovation at the intersection of wearable technology and digital health solutions. This news hub provides investors and industry professionals with essential updates on the company's advancements in smart health monitoring, strategic partnerships, and market leadership.
Access official press releases covering earnings reports, product launches (including Amazfit devices), technology collaborations, and operational developments. Our curated collection offers timely insights into ZEPP's proprietary health platforms, AI-driven innovations, and global expansion efforts within the $200B+ wearable technology sector.
Key updates include financial performance disclosures, R&D breakthroughs in biometric sensors, strategic alliances with health tech leaders, and regulatory milestones. The resource serves both casual observers tracking consumer wearable trends and professional analysts monitoring the competitive digital health landscape.
Bookmark this page for streamlined access to verified information about ZEPP's initiatives in personal wellness technology, without promotional bias or speculative commentary. Refresh regularly to stay current with developments impacting the company's position in global markets.
Zepp Health (NYSE: ZEPP), a global leader in smart wearables and health technology, has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (SEC).
The report is now accessible on the company's investor relations website at http://ir.zepp.com and the SEC's website at www.sec.gov. Shareholders and ADS holders can request free hardcopies of the annual report by contacting ir@zepp.com.
Zepp Health (NYSE: ZEPP) has launched the Amazfit Bip 6 smartwatch, priced at $79.99 USD. The new device features a 1.97-inch AMOLED display with 2,000 nits brightness, advanced BioTracker™ 6.0 PPG biometric sensor for health monitoring, and a two-week battery life.
The smartwatch offers 140+ workout modes, including HYROX Race and Smart Strength Training, along with offline navigation capabilities. Built with an aluminum alloy frame and 5 ATM water resistance, it comes in four colors: Black, Charcoal, Stone, and Red.
Key features include voice control through Zepp Flow™, Bluetooth connectivity for calls and messages, and integration with the Zepp App, which now includes a camera-powered food log feature available in select countries. The device aims to combine style, performance, and affordability for everyday fitness enthusiasts.
Zepp Health (NYSE: ZEPP) reported Q4 2024 financial results with revenue reaching US$59.5 million, showing a 40.2% quarter-over-quarter increase but a 28.3% year-over-year decline. Amazfit-branded products grew 43.4% quarter-over-quarter.
Key Q4 metrics include a gross margin of 36.8% (up from 34.7% YoY) and an adjusted operating loss of US$7.4 million. For full-year 2024, gross margin improved to 38.5% from 26.2% in 2023. The company ended 2024 with US$111 million in cash and successfully refinanced majority of short-term debts into long-term instruments.
Notable product developments include strong performance of T-Rex 3 in outdoor sports watches and positive reception of Active 2 and Bip 6 series. The company is advancing technology with OpenAI 4.5 integration and food logging features in Zepp OS.
For Q1 2025, Zepp projects revenues between US$40-45 million, representing 14-29% growth for Amazfit-branded products compared to Q1 2024.
Zepp Health (NYSE: ZEPP), a global leader in smart wearables and health technology, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for March 26, 2025, after market close.
The company will host an earnings conference call at 7:00 p.m. Eastern Time on the same day. A live and archived webcast will be available at http://ir.zepp.com, and a telephone replay will be accessible until April 2, 2025.
Amazfit, owned by Zepp Health (NYSE: ZEPP), has announced a multi-year partnership with Italian tennis star Jasmine Paolini, currently World No. 4 and the highest-ranked Italian singles player in WTA history. As part of the agreement, Paolini will wear Amazfit logo and smartwatch during matches and use the brand's fitness wearables, including Helio Ring, for tracking sleep and athletic recovery.
Paolini's achievements include reaching finals at the 2024 French Open (singles and doubles) and 2024 Wimbledon (singles), winning an Olympic gold medal in doubles, and securing two WTA singles and six doubles titles. The partnership aims to leverage Amazfit's advanced tracking technology to monitor key performance metrics like heart health, sleep quality, and exertion load.
Paolini joins Amazfit's roster of elite athletes, including Yeman Crippa, Gabby Thomas, and others. The company's product ecosystem includes Active, Cheetah and T-Rex series smartwatches, Helio smart ring, and the Zepp App with its new Food Log feature.
Amazfit, owned by Zepp Health (NYSE: ZEPP), has announced a four-year partnership with five-time Olympic Medalist Gabby Thomas as their latest athlete ambassador. Thomas, who emerged as the most decorated U.S. track and field athlete at the 2024 Paris Olympics with gold medals in 200m, 4x100m, and 4x400m events, will utilize Amazfit smartwatches during training and competition.
This marks Thomas' first smartwatch partnership, highlighting the importance of data in athletic performance. She will use Amazfit's devices to track heart rate, recovery, sleep quality, and nutrition through the Zepp app's food log feature. Thomas will also provide feedback to Amazfit's development teams on future product features and styles.
The partnership aligns with Amazfit's commitment to holistic health and well-being across physical fitness, sleep, mindfulness, and nutrition. Thomas joins other notable Amazfit athletes, including HYROX World Champions and Olympians.
Zepp Health (NYSE: ZEPP) has announced its participation in CES Pepcom and ShowStoppers media events to showcase its latest smart wearables and health technology innovations. The company will present several new products including:
The Amazfit Active 2 Smartwatch Series featuring Zepp Coach™, Zepp Flow™ voice assistant, and 160+ sports modes; the Amazfit V1TAL Prototype, a device with advanced nutritional tracking and high-definition video capture capabilities; and the Zepp Clarity Pixie hearing aids.
Additional innovations include a revamped Zepp App with enhanced features like Zepp Coach™, Zepp Aura, and Food Log, plus new health solutions for women powered by Wild.AI integration. The showcases will take place at Caesars Palace (January 6th) and Bellagio (January 7th).
Zepp Health (NYSE: ZEPP) has announced the launch of its new Amazfit Active 2 smartwatch at CES 2025. The device features a 1.32-inch AMOLED display with 2,000 nits brightness and comes in two versions: a premium model at $129.99 with leather strap and sapphire glass, and a standard version at $99.99 with silicone strap.
The watch incorporates advanced technology including the BioTracker™ 6.0 PPG biosensor, upgraded heart rate and sleep monitoring algorithms, and new sensors for altitude and movement tracking. It offers a 10-day battery life and includes features like Zepp Flow™ for voice control and Zepp Pay for contactless payments in Europe.
The device supports over 160 sports modes, offline maps with turn-by-turn navigation, and includes Zepp Coach™ for personalized training. Pre-orders are available in the US, with global release scheduled for February 2025.
Zepp Health (NYSE: ZEPP) has launched a 'Try Before You Buy' program for OTC hearing aids at CES 2025, addressing low adoption rates among adults with hearing loss. The initiative allows customers to test three models—Clarity Omni, Clarity One, and Clarity Pixie—in their homes before purchase.
The company introduced the Zepp Clarity Pixie, a next-generation hearing aid priced at $1,499, featuring a nearly invisible design, titanium alloy shell, IPX7 water resistance, and 17-hour battery life. The device includes Clarity Boost, Smart Phone Call support, and Find Device functionality, manageable through the Zepp Clarity App with eight customizable programs.
The program aims to tackle the low adoption rate of hearing aids, as only 15-30% of adults with mild-to-moderate hearing loss currently use them. All Zepp Clarity devices are FDA-Exempt Class II medical devices, targeting adults 18 and older, and come with lifetime customer support and certified audiologist access.
Zepp Health reported Q3 2024 financial results with revenues of US$42.5 million, representing a 48.9% decrease year-over-year. The company achieved a 40.6% gross margin, its highest quarterly margin, despite reporting a net loss of US$13.3 million. Amazfit branded sales showed a 10% quarter-over-quarter increase, marking the highest sequential growth in 2024. The company's T-Rex3 smartwatch launch received positive market feedback, while total units shipped decreased to 0.7 million from 2.8 million in Q3 2023. For Q4 2024, Zepp expects revenues between US$55-70 million, representing 29-65% growth for self-branded products compared to Q3.
